Miller Wealth Advisors’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
JAIC
Miller Wealth Advisors's STLN Position: Q3 2026 in Review
Miller Wealth Advisors held its Starling Oncology (STLN) position steady in Q3 2026 at 2,820 shares worth $17.8K. The position accounts for 0.01% of the portfolio, ranked #59.
Miller Wealth Advisors first reported a position in STLN in Q2 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold STLN as of Q3 2026.
- Miller Wealth Advisors held 2,820 shares of Starling Oncology worth $17.8K as of Q3 2026.
- Miller Wealth Advisors left its Starling Oncology share count unchanged in Q3 2026.
- Starling Oncology made up 0.01% of Miller Wealth Advisors's portfolio in Q3 2026, its #59 holding.
- Miller Wealth Advisors first reported a position in Starling Oncology in Q2 2026 and has held it in 2 quarters since.
- 128 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.
Based on Miller Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.